High serum sclerostin predicts the occur
β
Ardawi, Mohammed-Salleh M; Rouzi, Abdulrahim A; Al-Sibiani, Sharifa A; Al-Senani
π
Article
π
2012
π
American Society for Bone and Mineral Research
π
English
β 206 KB
## Abstract Sclerostin regulates bone formation by inhibiting Wnt pathway signaling. Low circulating sclerostin levels cause high bone mass. We hypothesized that postmenopausal women with increased sclerostin levels have a greater risk for osteoporosisβrelated fractures. We examined the association